CompaniesByCap
ELOX
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare

Eloxx Pharmaceuticals, Inc. Cash Flow 2010–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Jun 2014Jun 2013Jun 2012Jun 2011Jun 2010
Operating Activities
Operating Cash Flow-6.3M-4.7M-14.3M-31.8M-35.0M-28.2M-39.4M-31.4M-15.9M-8.8M-5.7M-4.9M-3.9M-4.4M-5.4M-4.7M
Depreciation & Amort.349,656293,629258,023143,274126,567
Investing Activities
Capital Expenditure66,00089,00040,000235,000237,00036,00010,0003,1941,2814,4612,0261,116
Free Cash Flow-31.9M-35.1M-39.4M-31.6M-16.2M-8.9M-5.7M-4.9M-3.9M-4.4M-5.4M-4.7M
Financing Activities
Dividends Paid000
Stock Buybacks

Eloxx Pharmaceuticals, Inc. Cash Flow — FAQ

Eloxx Pharmaceuticals, Inc. (ELOX) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ELOX's cash flow history?

The chart and table above show Eloxx Pharmaceuticals, Inc.'s cash flow by year and by quarter, including the growth rate.